• Ilaris

  Form: powder for injection solution

  Active substance	Dosage
  canakinumab	150 mg

  ATC: L04AC08

  Manufacturer: Novartis Pharma Stein AG (manufacturing, quality control, primary and secondary packaging, batch release)

• Ilaris

  Form: solution for injection

  Active substance	Dosage
  canakinumab	150 mg/ml

  ATC: L04AC08

  Manufacturer: Novartis Pharma Stein AG (manufacturing, quality control (excluding bioanalysis), primary packaging, secondary packaging)